Facebook Earnings Rise on Mobile Growth

Related Link: 

Facebook’s earnings jumped 34% in the holiday quarter on gains in mobile advertising, but its shares fell more than 2% in after-hours trading as expenses rose faster than revenue.

Reynolds, Lorillard Holders Back Deal

Related Link: 

Shareholders of Reynolds American and Lorillard voted to approve Reynolds’ $25 billion acquisition of Lorillard; the deal still needs regulatory approval.

Sony Bails Out of Music Streaming

Related Link: 

A shake-out in the market for music-streaming services appears to be gathering steam. Sony said it is shutting down its $10-a-month Music Unlimited at the end of March, four years after launching it in the U.S.

Samsung Pegs Rebound on Mobile Chips

Related Link: 

Samsung offered signs that the worst was likely over for its mobile division, as the company turns to mobile chips and cheaper handsets to spur a recovery in profit.

Amazon Starts Email Service for Companies

Related Link: 

Amazon announced an email service called WorkMail that is aimed at grabbing a slice of the corporate-email market largely controlled by Microsoft, and to a lesser extent Google.

Uber Denied New Delhi Taxi License

Related Link: 

Uber’s application to be recognized as a radio-dispatched taxi company in Delhi has been rejected in the latest roadblock for the car-hailing company.

The Technology that Unmasks Your Hidden Emotions

Related Link: 

Startups are combining psychology and big data to analyze people’s faces and potentially discover their deepest emotions—while amassing an enormous visual database that is breeding privacy concerns.

Scrapped: Oil Prices Shelve an $11 Billion Gulf Coast Project

Related Link: 

Sasol said it was shelving an $11 billion project on Louisiana’s Gulf Coast, imperiling one of the largest foreign investments on U.S. soil because of the plunge in oil prices.

EU Approves Novartis-Glaxo Deals

Related Link: 

The drug giants won European Union regulatory approval for a complicated series of deals worth more than $20 billion that will focus Novartis’ scope and turn Glaxo into a vaccines-and-consumer-drug powerhouse.

China Raps Alibaba for Fakes

Related Link: 

The Chinese government accused e-commerce giant Alibaba of failing to crack down on the sale of fake goods, bribery and other illegal activity on its sites in a rare public dispute with one of the country’s most prominent companies.

Syndicate content